Product
Help
Pricing
About
Jobs
Log in
Get started
Funder
Add to collection
ViiV Healthcare
Homepage URL:
viivhealthcare.com
Description:
pharmaceutical company
Country:
GB
ROR:
01cc9yk21
Wikidata ID:
wiki/Q7929051
Crossref ID:
100010877
DOI:
10.13039/100010877
OpenAlex ID:
F4320312382
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
2024
·
Ndiaye, Matar
, Lespez, Laurent
, et al.
·
Monash University Research Portal (Monash University)
·
23,869
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
2011
·
Myron S. Cohen
, Ying Q. Chen
, et al.
·
New England Journal of Medicine
·
6,865
PDF
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
2020
·
Andre C. Kalil
, Thomas F. Patterson
, et al.
·
New England Journal of Medicine
·
1,836
COVID-19: the gendered impacts of the outbreak
2020
·
Clare Wenham
, Julia Smith
, et al.
·
The Lancet
·
1,699
PDF
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
2017
·
Adam Trickey
, Margaret T May
, et al.
·
The Lancet HIV
·
1,084
PDF
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
2019
·
Alison J Rodger
, Valentina Cambiano
, et al.
·
The Lancet
·
1,017
PDF
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
2014
·
Colette J Smith
, Lene Ryom
, et al.
·
The Lancet
·
928
PDF
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
2021
·
Raphael J. Landovitz
, Deborah Donnell
, et al.
·
New England Journal of Medicine
·
900
PDF
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
2010
·
Julio SG Montaner
, Viviane D Lima
, et al.
·
The Lancet
·
778
PDF
Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
2014
·
J. Schouten
, F. W. Wit
, et al.
·
Clinical Infectious Diseases
·
752
PDF
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
2021
·
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
, Pere Domingo
, et al.
·
JAMA
·
679
PDF
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
2016
·
Huldrych F. Günthard
, Michael S. Saag
, et al.
·
JAMA
·
656
PDF
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
2019
·
David J. Pinato
, Sarah Howlett
, et al.
·
JAMA Oncology
·
620
PDF
Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study
2011
·
B. Hasse
, B. Ledergerber
, et al.
·
Clinical Infectious Diseases
·
608
PDF
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
2020
·
Susan Swindells
, Jaime-Federico Andrade-Villanueva
, et al.
·
New England Journal of Medicine
·
594
PDF
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
2022
·
Sinead Delany-Moretlwe
, James P Hughes
, et al.
·
The Lancet
·
586
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
2022
·
Rajesh T. Gandhi
, Roger Bedimo
, et al.
·
JAMA
·
557
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
2013
·
Francois Raffi
, Anita Rachlis
, et al.
·
The Lancet
·
548
Validating a Shortened Depression Scale (10 Item CES-D) among HIV-Positive People in British Columbia, Canada
2012
·
Wendy Zhang
, Nadia O’Brien
, et al.
·
PLoS ONE
·
542
PDF
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
2023
·
Adam Trickey
, Caroline A Sabin
, et al.
·
The Lancet HIV
·
530
PDF
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
2013
·
Pedro Cahn
, Anton L Pozniak
, et al.
·
The Lancet
·
516
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
2014
·
Bonaventura Clotet
, Judith Feinberg
, et al.
·
The Lancet
·
507
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
2014
·
Julian H. Elliott
, Fiona Wightman
, et al.
·
PLoS Pathogens
·
505
PDF
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
2023
·
Steven K. Grinspoon
, Kathleen V. Fitch
, et al.
·
New England Journal of Medicine
·
502
PDF
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
2017
·
David A Margolis
, Juan Gonzalez-Garcia
, et al.
·
The Lancet
·
499
Show more works
View as search
Works count:
3,365
Citation count:
129,000
H-index:
129
I10-index:
1,709
2-year mean citedness:
32.74
Awards count:
108
Year
Topic
Type
